Clinical Trials in Wŏnju, Gangwon-do
23 recruiting
Showing 1–20 of 23 trials
Recruiting
Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Takeda268 enrolled193 locationsNCT06233461
Recruiting
Phase 3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals5,700 enrolled492 locationsNCT07517263
Recruiting
Phase 2
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Genentech, Inc.224 enrolled82 locationsNCT06979336
Recruiting
Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart FailureAcute Heart Failure
Colorado Prevention Center5,200 enrolled299 locationsNCT06008197
Recruiting
Phase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection RecurrenceClostridium DifficileClostridioides Difficile Infection+7 more
Vedanta Biosciences, Inc.852 enrolled215 locationsNCT06237452
Recruiting
Asciminib RMP Study
Chronic Myeloid Leukemia
Novartis Pharmaceuticals600 enrolled17 locationsNCT05943522
Recruiting
Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Takeda207 enrolled141 locationsNCT06254950
Recruiting
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Arthritis, RheumatoidColitis Ulcerative
Eisai Korea Inc.2,040 enrolled64 locationsNCT06246123
Recruiting
A 24-week rPMS Study in Real-world Setting for Enerzair
Asthma
Novartis Pharmaceuticals600 enrolled20 locationsNCT05274425
Recruiting
Phase 4
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Asthma
Sanofi1,324 enrolled249 locationsNCT05097287
Recruiting
Not Applicable
Left Bundle Branch Area Pacing Versus Right Ventricular Pacing in Atrioventricular Block With Preserved Ejection Fraction
Atrioventricular BlockConduction System PacingLeft Bunde Branch Area Pacing
Samsung Medical Center200 enrolled4 locationsNCT07464041
Recruiting
Phase 2
Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19
COVID-19
Traws Pharma, Inc.90 enrolled15 locationsNCT07157007
Recruiting
Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Crohn's DiseaseUlcerative Colitis
Takeda183 enrolled16 locationsNCT06764615
Recruiting
Not Applicable
Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia
Arrhythmia
Wonju Severance Christian Hospital588 enrolled3 locationsNCT06250712
Recruiting
Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients
FGF23-related Hypophosphataemic Rickets and Osteomalacia
Kyowa Kirin Korea Co., Ltd.100 enrolled13 locationsNCT06202027
Recruiting
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
Asthma
Novartis Pharmaceuticals600 enrolled18 locationsNCT05217810
Recruiting
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea
Graft-Versus-Host Disease
Novartis Pharmaceuticals127 enrolled11 locationsNCT05621733
Recruiting
Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital
Sudden Hearing LossSSNHL(Sudden Sensory Neural Hearing Loss)Hearing Loss, Idiopathic Sudden Sensorineural+1 more
Wonju Severance Christian Hospital1,000 enrolled1 locationNCT05474963
Recruiting
Not Applicable
Taekwondo for Axial Spondyloarthritis
Ankylosing SpondylitisAxial Spondyloarthritis
Wonju Severance Christian Hospital24 enrolled1 locationNCT06823726
Recruiting
Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT and SPIKEVAX X Injection.
ModernaTX, Inc.4,206 enrolled24 locationsNCT06333704